EKF Diagnostics (LON:EKF) Stock Price Crosses Above 200-Day Moving Average – Should You Sell?

EKF Diagnostics Holdings plc (LON:EKF) passed above its 200-day moving average during trading on Tuesday . The stock has a 200-day moving average of GBX 26.77 and traded as high as GBX 27. EKF Diagnostics shares last traded at GBX 25.30, with a volume of 569,178 shares.

EKF Diagnostics Price Performance

The firm has a market capitalization of £109.29 million, a price-to-earnings ratio of 18.74 and a beta of 0.54. The company has a quick ratio of 1.77, a current ratio of 4.62 and a debt-to-equity ratio of 1.56. The company’s 50 day moving average price is GBX 25.87 and its 200 day moving average price is GBX 26.77.

Insiders Place Their Bets

In other news, insider Julian Baines acquired 85,000 shares of the business’s stock in a transaction dated Monday, December 15th. The shares were acquired at an average cost of GBX 23 per share, with a total value of £19,550. Insiders own 39.72% of the company’s stock.

EKF Diagnostics Company Profile

EKF is an AIM-listed global diagnostics business focussed on:

● Point-of-Care analysers in the key areas of Hematology and Diabetes

● Life Sciences services provide specialist manufacture of enzymes and custom products for use in diagnostic, food and industrial applications.

EKF has headquarters in Penarth (near Cardiff) and operates five manufacturing sites across the US and Germany, selling into over 120 countries world-wide.